24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Polypid
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:06
Google’s Sergey Brin calls UN “blatantly antisemitic,” condemns Gaza report
16:30
Ryft raises $8M with support from Wiz founders to help enterprises take charge of cloud data
16:24
Full list of Israeli high-tech funding rounds in 2025
16:00
Ex-Cognigo founders raise $20M Series A to bring AI automation to CFOs
More stories
Buzz
Most popular
Daily
Weekly
1
Intel offers up to 19 salaries to laid-off employees if they don’t fight firings
2
Inside Intel's painful cuts: Who's being let go and why
3
Intel offloads $900 million in Mobileye shares to ease cash crunch
4
Intel CEO: "The strength, resilience and resolve of Intel Israel's team has no bounds"
5
Remote work’s dark side: The Soham Parekh story
More news
Polypid
6 stories about Polypid
Biotech Company Polypid Raises $15 Million
07.11.18
|
Lilach Baumer
Israel-based Polypid develops encapsulating drug delivery technology that enables extended and localized release in the body
CTech’s Sunday Roundup of Israeli Tech News
25.03.18
|
CTech
U.S. court charges Israeli CEO with binary options fraud. Stock market downturn leads biotech company Polypid to backtrack on IPO
Stock Market Downturn Leads Biotech Company Polypid to Backtrack on IPO
25.03.18
|
Dror Reich
The Israel-based company has postponed its planned IPO after Nasdaq, Dow Jones trended down heavily last week
CTech’s Thursday Israeli Tech News Roundup
15.03.18
|
CTech
Israel-based defense and homeland security manufacturer and contractor Elbit wins a $65 million contract with an unnamed Asian-Pacific country. In protest of new bonus plan, Teva sued by Israeli employees
Biotech Company Polypid Aims to Raise $75 Million with Nasdaq IPO
15.03.18
|
Dror Reich
The Israel-based company develops a pharmaceutical mechanism that slows down drug delivery
Controlled Drug Release Company Polypid Attempts Second Nasdaq IPO
11.02.18
|
Dror Reich
The Israel-based company is looking to raise up to $86.25 million to fund clinical development and trials and manufacturing activities